| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 5.728 | 30.937 | 39.497 | 53.849 | 74.147 | 74.745 |
| Total Income - EUR | - | - | - | - | 5.728 | 30.937 | 39.497 | 53.849 | 74.147 | 74.745 |
| Total Expenses - EUR | - | - | - | - | 69 | 7.525 | 7.851 | 9.695 | 12.220 | 14.666 |
| Gross Profit/Loss - EUR | - | - | - | - | 5.659 | 23.412 | 31.645 | 44.154 | 61.927 | 60.079 |
| Net Profit/Loss - EUR | - | - | - | - | 5.487 | 23.128 | 31.258 | 43.626 | 61.200 | 57.881 |
| Employees | - | - | - | - | 0 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Senologie Dr. Bădilă Codruța S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 0 | 0 | 805 | 1.034 |
| Current Assets | - | - | - | - | 5.728 | 24.323 | 32.441 | 44.938 | 62.090 | 58.607 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 3.503 | 19.670 | 26.526 | 34.381 | 47.920 | 46.880 |
| Cash | - | - | - | - | 2.226 | 4.653 | 5.915 | 10.556 | 14.170 | 11.727 |
| Shareholders Funds | - | - | - | - | 5.530 | 23.178 | 31.307 | 43.675 | 61.249 | 57.930 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 199 | 1.145 | 1.134 | 1.263 | 1.645 | 1.712 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Senologie Dr. Bădilă Codruța S.r.l.